Barclays
APYX icon

Barclays’s Apyx Medical APYX Stock Holding History

Barclays’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.62K Buy
+439
New +$1.64K ﹤0.01% 4869
2023
Q4 		– Sell
-14,284
Closed -$45.7K – 5219
2023
Q3 		$45.7K Buy
+14,284
New +$66.6K ﹤0.01% 3912
2023
Q1 		– Sell
-842,145
Closed -$1.97M – 5076
2022
Q4 		$1.97M Buy
+842,145
New +$2.57M ﹤0.01% 2279
2021
Q3 		– Sell
-546
Closed -$6K – 4735
2021
Q2 		$6K Buy
+546
New +$5.41K ﹤0.01% 4726
2021
Q1 		– Sell
-10,792
Closed -$78K – 4676
2020
Q4 		$78K Sell
10,792
-4,634
-30% -$30.7K ﹤0.01% 4232
2020
Q3 		$73K Sell
15,426
-3,079
-17% -$15.2K ﹤0.01% 4408
2020
Q2 		$102K Buy
+18,505
New +$76.9K ﹤0.01% 4503
2020
Q1 		– Sell
-9
Closed – – 6116
2019
Q4 		$0 Sell
9
-16,816
-100% -$121K ﹤0.01% 6321
2019
Q3 		$114K Sell
16,825
-9,100
-35% -$64.6K ﹤0.01% 5376
2019
Q2 		$174K Buy
25,925
+25,762
+15,805% +$140K ﹤0.01% 5241
2019
Q1 		$1K Sell
163
-123,254
-100% -$954K ﹤0.01% 6894
2018
Q4 		$800K Buy
+123,417
New +$748K ﹤0.01% 3340
2018
Q3 		– Sell
-44
Closed – – 7091
2018
Q2 		$0 Sell
44
-520
-92% -$1.92K ﹤0.01% 6943
2018
Q1 		$2K Buy
564
+506
+872% +$1.3K ﹤0.01% 6889
2017
Q4 		$0 Sell
58
-6
-9% -$19 ﹤0.01% 6906
2017
Q3 		$0 Sell
64
-214
-77% -$552 ﹤0.01% 6826
2017
Q2 		$1K Buy
278
+184
+196% +$452 ﹤0.01% 6485
2017
Q1 		$0 Buy
+94
New +$312 ﹤0.01% 6736

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Barclays's APYX Position: Q1 2026 in Review

Barclays opened a new position in Apyx Medical (APYX) in Q1 2026: 439 shares worth $1.62K. The stake represents ﹤0.01% of the portfolio and ranks #4869 among its holdings. This is a return to the name: Barclays previously reported a position in APYX as recently as Q3 2023.

Barclays first reported a position in APYX in Q1 2017 and has held it in 18 quarters since. The position peaked at $1.97M in Q4 2022. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Barclays held 439 shares of Apyx Medical worth $1.62K as of Q1 2026.
  • Apyx Medical was a new Barclays position in Q1 2026.
  • Apyx Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4869 holding.
  • Barclays first reported a position in Apyx Medical in Q1 2017 and has held it in 18 quarters since.
  • Barclays's Apyx Medical position peaked at $1.97M in Q4 2022.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.